The Exchange had sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE asked Lotus Eye Hospital to clarify why segment-wise details were missing from its March 2025 quarter results filed under SEBI's Listing Regulations. The exchange flagged this as non-compliance with Regulation 33, which governs how listed companies report quarterly financial results. The company has since submitted its response with the requested clarification. This is a routine exchange query related to disclosure format, not a penalty or formal action. Segment reporting is a standard requirement to show revenue and performance split across different business lines.
This is a minor compliance issue and unlikely to move the stock price. Shareholders should monitor whether the company faces any further action from SEBI, but routine clarifications of this nature are common among small-cap companies and are usually resolved without penalties.